| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$27 |
Q4 FY25 Quarterly Activities Report & Appendix 4C
|
22 Jul 2025 8:57AM |
$0.095 |
$0.038 |
fallen by
60%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported several new clinical and commercial partnerships during the quarter.
- Announced advancement in the company’s therapeutic pipeline and diagnostic offerings.
- Strengthened collaborations with pharmaceutical and research organizations.
- Received grant funding and engaged in new research projects.
- Maintained a robust cash position with detailed disclosure of operational cash flows and expenditures.
- Outlined continued efforts to expand product adoption in the diagnostics market.
- Emphasized discipline in financial management and strategic investments.
- Provided Appendix 4C detailing quarterly cash flow and financial summary.
- Reiterated commitment to growth in microbial diagnostics and therapeutics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Copper Search Limited (CUS) ORDINARY FULLY PAID |
Materials |
- |
Application for quotation of securities - CUS
|
22 Jul 2025 8:55AM |
$0.019 |
$0.018 |
fallen by
5.26%
|
|
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$220 |
Corporate Presentation
|
22 Jul 2025 8:55AM |
$0.190 |
$0.380 |
risen by
100%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$447 |
Cogstate FY2025 Results Webinar
|
22 Jul 2025 8:54AM |
$1.780 |
$2.630 |
risen by
47.75%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$6 |
Ultrafine soil sampling at Challenger West And Highway
|
22 Jul 2025 8:53AM |
$0.060 |
$0.047 |
fallen by
21.67%
|
|
T88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Taiton Resources Limited completed an Ultrafine™ soil sampling program at Challenger West and Highway within the Lake Labyrinth Shear Zone.
- A total of 765 soil samples were collected and analyzed for multiple elements.
- New geochemical anomalies for gold, silver, copper, lead, and zinc were identified.
- Geochemical results correlate with structural trends interpreted from geophysical data.
- The results suggest potential mineralized systems and justify further exploration, including targeted drilling.
- The survey reinforces the exploration potential of the LLSZ as a mineralized corridor.
- The methodology, findings, and planned follow-up activities are detailed in the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rokeby Resources Limited (RKB) ORDINARY FULLY PAID |
Materials |
$12 |
Drilling Underway at Hurricane
|
22 Jul 2025 8:51AM |
$0.012 |
$0.004 |
fallen by
66.67%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,466 |
June 2025 Quarterly Activities and Cash Flow
|
22 Jul 2025 8:51AM |
$1.250 |
$16.025 |
risen by
1,182%
|
|
SRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities focused on the advancement of the Sunrise Project.
- Updates provided on partnerships, funding, and stakeholder engagement.
- Details on exploration and development activities during the quarter.
- Financial statements and cash flow analyses included, covering operating, investing, and financing activities.
- Management commentary discusses the company’s ongoing strategy and future outlook.
- The report outlines risk factors and mitigation strategies relevant to SRL’s operations.
- Information on regulatory, environmental, and community engagement initiatives.
- Discussion of significant events and operational milestones achieved within the quarter.
- Future plans and objectives for the upcoming quarters are presented.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$6 |
Cummins Project Drilling Update
|
22 Jul 2025 8:49AM |
$0.011 |
$0.008 |
fallen by
27.27%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Core Energy Minerals Ltd (CR3) provided a drilling update for the Cummins Project.
- Significant lithium mineralization was intersected, with high-grade spodumene observed.
- Drilling results confirmed thick, continuous pegmatite zones.
- Geological mapping and assays support the potential for a substantial lithium resource.
- The Cummins Project is a key asset in South Australia for lithium exploration.
- The company plans to continue drilling to further define and expand the resource.
- Core Energy Minerals aims to deliver a JORC-compliant resource estimate soon.
- The update reaffirms the strategic value of the Cummins Project in CR3's portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$447 |
Change of Director's Interest Notice (Amended) - BOC
|
22 Jul 2025 8:48AM |
$1.780 |
$2.630 |
risen by
47.75%
|
|
| PPK Group Limited (PPK) ORDINARY FULLY PAID |
Materials |
$32 |
PPE launches new products that align with the CHB program
|
22 Jul 2025 8:46AM |
$0.435 |
$0.355 |
fallen by
18.39%
|
|
PPK - Price-sensitive ASX Announcement
Full Release
Key Points
- PPK Group Limited has launched new PPE products.
- The new products are designed to align with the CHB program.
- PPK emphasizes innovation and safety in its product development.
- The announcement provides details on the new PPE products and their uses.
- The company aims to address workplace safety and health with these offerings.
- The launch reflects PPK's strategic focus on advanced safety solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$345 |
Q4 FY2025 Update Presentation
|
22 Jul 2025 8:45AM |
$0.775 |
$0.708 |
fallen by
8.71%
|
|
PPS - Price-sensitive ASX Announcement
Full Release
Key Points
- Q4 FY2024 total Funds Under Administration (FUA) reached $55.6 billion, a significant year-on-year increase.
- Net inflows for the quarter were $1.2 billion, supporting continued growth momentum.
- Australian platform FUA increased by 18% over the last 12 months.
- International platform saw net inflows and improved engagement with advisers and clients.
- Ongoing investment in technology to enhance platform features and operational efficiency.
- Expansion of model portfolio offerings and managed account capabilities.
- Focus on adviser experience, including digital tools and client reporting enhancements.
- Continued progress on key strategic initiatives to drive sustainable growth.
- Positive outlook for FY2025, with further product innovation and market penetration planned.
- Praemium's net revenue and cost control measures have underpinned improved profit margins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Falcon Metals Ltd (FAL) ORDINARY FULLY PAID |
Materials |
$90 |
Soil anomaly extended to 5.8km strike at Errabiddy
|
22 Jul 2025 8:44AM |
$0.710 |
$0.420 |
fallen by
40.85%
|
|
| West Coast Silver Limited (WCE) ORDINARY FULLY PAID |
Materials |
$36 |
FAL: Soil anomaly extended to 5.8km strike at Errabiddy
|
22 Jul 2025 8:44AM |
$0.150 |
$0.098 |
fallen by
34.67%
|
|
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$30 |
More Visual Copper & Gold at Chancho al Palo, Peru
|
22 Jul 2025 8:44AM |
$0.081 |
$0.093 |
risen by
14.81%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Solis Minerals Ltd has announced visual copper and gold mineralization at the Chancho al Palo project in Peru.
- Multiple drill holes show extensive copper mineralization, confirming porphyry-style mineralization over significant intervals.
- The results support the potential for a substantial copper-gold resource at the project.
- Ongoing drilling is enhancing geological understanding and outlining the scale of the mineralized system.
- Further drilling and geophysical surveys are planned to define the resource and economic potential.
- The company’s exploration focus is on expanding and delineating mineralization zones at Chancho al Palo.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$38 |
Breakthrough Results from RRAM Sensor Integration
|
22 Jul 2025 8:44AM |
$0.022 |
$0.031 |
risen by
40.91%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dorsavi Ltd (DVL) announces breakthrough results from integrating RRAM sensors into their wearable technology.
- RRAM integration delivers improved sensitivity, miniaturization, and lower power consumption.
- The technology is aimed at clinical, sports, and occupational health markets.
- Enhanced data accuracy and real-time biomechanical monitoring are key benefits.
- Pilot trials and internal validation studies confirm technical and functional advantages.
- Dorsavi plans further development and commercialization of RRAM-enabled products.
- The company positions itself as an industry leader in wearable sensor innovation.
- The announcement details commercial opportunities arising from RRAM sensor technology.
- Next steps include expanding industry partnerships and securing regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$345 |
Q4 FY2025 Update
|
22 Jul 2025 8:43AM |
$0.775 |
$0.708 |
fallen by
8.71%
|
|
PPS - Price-sensitive ASX Announcement
Full Release
Key Points
- Praemium Limited released its Q4 FY2025 update with strong financial and operational results.
- Record quarterly net inflows were reported, reflecting increased adviser adoption and positive market conditions.
- Platform funds under administration (FUA) reached new highs, buoyed by growth in both the Australian and International businesses.
- The PPS platform saw enhancements in digital onboarding and adviser tools, supporting efficiency and client engagement.
- Initiatives in adviser education and engagement were emphasized as key drivers for the progress.
- The company continues to invest in technology while managing costs effectively.
- Strategic priorities for the upcoming year include expanding platform capabilities, improving client experience, and driving further net inflows.
- Outlook remains positive based on adviser demand, ongoing technology improvements, and a strong business pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$15 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
22 Jul 2025 8:43AM |
$0.420 |
$0.067 |
fallen by
84.05%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited (GSS) released its Quarterly Activities Report and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- Cash receipts during the quarter were $2.3 million, predominantly from product sales and government grants.
- Total cash outflows for the quarter were $4.2 million, with primary expenditures on product manufacturing, research and development, and staff costs.
- Net cash used in operating activities was $1.9 million, an improvement compared to the prior quarter.
- The company had a cash balance of $15.2 million at the end of the quarter.
- Key operational highlights include progress on clinical trials for the EasyScreen™ Gastrointestinal Parasite Detection Kit and regulatory submissions in the USA and Europe.
- Genetic Signatures continued its international expansion, focusing on increasing market share in Europe and the USA.
- Research and development efforts were ongoing to broaden the diagnostic product portfolio.
- No significant financing or investing activities were reported during the quarter.
- The company maintains sufficient funding to execute its planned commercial and R&D activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
- |
Insignia Financial 4Q25 Quarterly Business Update
|
22 Jul 2025 8:39AM |
$3.930 |
$4.790 |
risen by
21.88%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- FUMA increased to $330.3 billion as of 30 June 2025.
- Wrap FUA exceeded $100 billion, driven by MLC Expand growth.
- Total net inflows for the quarter were $2.1 billion.
- Transition of Master Trust functions to SS&C completed.
- Scheme implementation deed with CC Capital to acquire Insignia shares.
- Capital position strengthened with extended syndicated facility.
- Proposed change of auditor to EY, subject to approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
- |
Insignia Financial 4Q25 Quarterly Business Update
|
22 Jul 2025 8:39AM |
$3.930 |
$4.790 |
risen by
21.88%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- FUMA increased by $8.5 billion to $330.3 billion.
- Wrap FUA exceeded $100 billion, driven by MLC Expand.
- Successful transition of Master Trust functions to SS&C.
- Launch of MLC Retirement Boost on the MLC Expand platform.
- Entered a scheme implementation deed with CC Capital.
- Strengthened capital position through facility extension.
- Proposed appointment of EY as the new auditor.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
22 Jul 2025 8:39AM |
$1.740 |
$1.950 |
risen by
12.07%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
- |
IFL enters into SID
|
22 Jul 2025 8:39AM |
$3.930 |
$4.790 |
risen by
21.88%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Insignia Financial Ltd entered into a Scheme Implementation Deed with CC Capital Partners
- Scheme involves acquisition of all issued shares for $4.80 per share
- Scheme Consideration represents a 56.9% premium to prior closing share price
- Insignia Financial Board recommends the Scheme, absent a superior proposal
- Scheme subject to shareholder and regulatory approvals
- Implementation expected in the first half of 2026
- Conditions include approvals from APRA, FIRB, ACCC
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$33 |
Wisr Q4FY25 Market Update and Investor Call
|
22 Jul 2025 8:39AM |
$0.026 |
$0.019 |
fallen by
26.92%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$15 |
Strategic Partnership with Tecan and Repado
|
22 Jul 2025 8:38AM |
$0.420 |
$0.067 |
fallen by
84.05%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited (GSS) has signed strategic partnership agreements with Tecan and Repado.
- The agreements aim to integrate GSS’s EasyScreen sample-to-result workflow with Tecan’s and Repado’s laboratory automation solutions.
- Collaboration will allow seamless automation and scalability for diagnostic laboratories.
- Integration targets improved efficiency and high-throughput infectious disease testing.
- Partnerships are designed to expand GSS's global footprint and commercial reach.
- The combined effort will reduce manual processes and streamline lab automation.
- The agreements support GSS’s molecular diagnostic solutions in clinical laboratories worldwide.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$37,350 |
Update - Notification of buy-back - ALL
|
22 Jul 2025 8:33AM |
$67.200 |
$62.065 |
fallen by
7.64%
|
|
| Robex Resources Inc. (RXR) ORDINARY FULLY PAID |
Materials |
- |
Company Secretary Appointment and Resignation
|
22 Jul 2025 8:33AM |
$3.660 |
$7.230 |
risen by
97.54%
|
|
Call 1300 880 160
Start a chat
Schedule a call
